New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sabinsa Intellectual Property Strengthens with Granting of Two Additional International Patents

Sabinsa, the international ingredients company, has received notification that two additional patents have been granted.

The company’s Garcitrin® product is now protected by Japanese patent number 4205943 for “Bioavailable composition of natural and synthetic HCA.” The hydroxycitric acid (HCA) has been uniquely combined with garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica fruits; the result is GarCitrin®. In GarCitrin®, garcinol enhances the biological action of HCA and also contributes antioxidant activity to the formulation. A 12-week, double blind clinical with over 40 patients proved GarCitrin® is statistically more effective than HCA alone in:

 reducing total body weight and body mass index
 reducing body fat
 increasing lean body mass
 reducing levels of appetite perception

Garcitrin® is also protected by other international patents, U.S.A. 7,063,861; AU773081; EP1254209; NZ518116.
The Australian patent office granted patent number AU 2006235807, for the “Use of Tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa.” This off-white Curcumin powder is ideal for cosmetic applications looking for superior antioxidant effectiveness.

The composition of tetrahydrocurcuminoids helps to support healthy aging of tissues through:
 regulating random intracellular protein crosslinking
 optimizing cell electric potential
 increasing intracellular transglutaminase activity
 reducing "age spots" due to lipofuscin formation

Come visit Sabinsa, a Gold Sponsor at the SupplyExpo, booth #317, in Anaheim, CA from March 6-8.

Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 20 years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100+ scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher, with some certified Halal.

For more information please visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.